29-Jan-18, KPMG
We have witnessed a surge in healthcare investment by Chinese companies in Australia in recent years. AUD 2.55 bn was invested in 2015 and AUD1.58 bn in 2017 through several very large deals. These include the acquisition of hospital operator Healthe Care and the acquisition of Swisse Wellness.
%20KPMG.jpg "Demystifying Chinese investment in Australian healthcare (c) KPMG")
Image: KPMG
Investment has been concentrated on the health supplement and healthcare service sectors in Australia with no large investments in pharmaceuticals, biotechnology or aged care to date.
The rise in Chinese healthcare investment reflects Australia’s reputation for developing, testing and producing high-end products and services which can be deployed locally and exported. International free trade agreements, combined with progressive domestic Australian initiatives such as the Medical Research and Innovation Strategy.